Plasma Levels of Bevacizumab and Vascular Endothelial Growth Factor After Low-Dose Bevacizumab Treatment for Retinopathy of Prematurity in Infants

Writing Committee for the Pediatric Eye Disease Investigator Group

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Plasma Levels of Bevacizumab and Vascular Endothelial Growth Factor After Low-Dose Bevacizumab Treatment for Retinopathy of Prematurity in Infants'. Together they form a unique fingerprint.

Medicine & Life Sciences